A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference23 articles.
1. Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma;Neijt;Lancet,1984
2. Intraperitoneal cisplatin with systemic thiosulfate protection;Howell;Ann Int Med,1982
3. Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma;Reichman;J Clin Oncol,1989
4. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy;Howell;J Clin Oncol,1987
5. Disease oriented phase II trial with etoposide (NSC 141540) in cisplatin refractory ovarian cancer;Kühnle;Tumor Diagnostik Therapie,1984
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Laparoscopic Placement of PAP Catheters for Intraperitoneal Chemotherapy in Ovarian Carcinoma;Gynecologic Oncology;1998-04
2. Intraperitoneal Carboplatin with or without Interferon-α in Advanced Ovarian Cancer Patients with Minimal Residual Disease at Second Look: A Prospective Randomized Trial of 111 Patients;Gynecologic Oncology;1997-06
3. Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer;European Journal of Cancer;1995-01
4. Mechanisms of Cisplatin Resistance and Its Reversal In Human Tumors;Alternative Mechanisms of Multidrug Resistance in Cancer;1995
5. Intraperitoneal Carboplatin and Etoposide for Persistent Epithelial Ovarian Cancer: Analysis of Results by Prior Sensitivity to Platinum-Based Regimens;Gynecologic Oncology;1993-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3